CS252518B1 - 4-(3-alkylamino-2-hydroxypropoxy)-3-(alkoxymethyl)phenylalkylketones and method of their preparation - Google Patents
4-(3-alkylamino-2-hydroxypropoxy)-3-(alkoxymethyl)phenylalkylketones and method of their preparation Download PDFInfo
- Publication number
- CS252518B1 CS252518B1 CS856717A CS671785A CS252518B1 CS 252518 B1 CS252518 B1 CS 252518B1 CS 856717 A CS856717 A CS 856717A CS 671785 A CS671785 A CS 671785A CS 252518 B1 CS252518 B1 CS 252518B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- formula
- alkylamino
- hydroxypropoxy
- same
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title claims description 7
- -1 phenylalkyl ketones Chemical class 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000011541 reaction mixture Substances 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 230000003197 catalytic effect Effects 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000004849 alkoxymethyl group Chemical group 0.000 claims 3
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims 2
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 238000006555 catalytic reaction Methods 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 8
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N phenyl propionaldehyde Natural products CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000001530 fumaric acid Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- PZKFGEYIQXHNGA-UHFFFAOYSA-N C(C=CC(=O)O)(=O)O.C1(=CC=CC=C1)C(C)=O Chemical compound C(C=CC(=O)O)(=O)O.C1(=CC=CC=C1)C(C)=O PZKFGEYIQXHNGA-UHFFFAOYSA-N 0.000 description 2
- LIIKBWAZPUBUTR-WLHGVMLRSA-N C(\C=C\C(=O)O)(=O)O.C(CC)(=O)C1=CC=CC=C1 Chemical compound C(\C=C\C(=O)O)(=O)O.C(CC)(=O)C1=CC=CC=C1 LIIKBWAZPUBUTR-WLHGVMLRSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- QWXUJPJVNKCDKJ-UHFFFAOYSA-N 1-(tert-butylamino)-3-chloropropan-2-ol;hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)CCl QWXUJPJVNKCDKJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- BQIPXWYNLPYNHW-UHFFFAOYSA-N metipranolol Chemical compound CC(C)NCC(O)COC1=CC(C)=C(OC(C)=O)C(C)=C1C BQIPXWYNLPYNHW-UHFFFAOYSA-N 0.000 description 1
- 229960002704 metipranolol Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- AQFROTXMDPNEJE-UHFFFAOYSA-N n-(oxiran-2-ylmethyl)propan-2-amine Chemical compound CC(C)NCC1CO1 AQFROTXMDPNEJE-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
Vynález sa týká nových l-aryloxy-3-amíno-2-propanolov všeobecného vzorca I,The invention relates to novel 1-aryloxy-3-amino-2-propanols of the general formula I,
OH iOH i
RZ R Z
CO kdeWHAT WHERE
R1 znamená izopropyl, terc.butyl,R 1 is isopropyl, tert-butyl,
R2 je alyl, cyklohexyl,R 2 is allyl, cyclohexyl,
R3 je metyl, etyl.R 3 is methyl, ethyl.
Vynález sa týká tiež solí substituovaných aryloxyamínopropanolov všeobecného vzorca I, ako i spůsobov, ktorými možno deriváty aryloxyamínopropanolov všeobecného vzorca I připravit.The invention also relates to salts of substituted aryloxyaminopropanols of the formula I as well as to processes by which the aryloxyaminopropanols of the formula I can be prepared.
Na základe literárnej rešerše ako i patentovej literatúry, látky uvedené pod všeobecným vzorcom I sú originálně, doteraz v literatúre nepopísané, ktoré vykazujú typické účinky betalytík, ako je to u aryloxyamínopropanolov iným spůsobom substituovaných (Čs. pat. 128 471, US pat. 3 466 376, DOS 2645 710, 2 106 209). Připravené látky vykazujú významnú antiizoprenalínovú aktivitu, porovnatelná so štandardom praktololom. Antiarytmická aktivita je nižšia ako standard propranolol.Based on the literature search and the patent literature, the compounds of formula (I) are original, not yet described in the literature, which exhibit the typical effects of betalytics, as is the case with aryloxyaminopropanols substituted in other ways (U.S. Pat. No. 128,471, U.S. Pat. 3,446). 376, DOS 2645 710, 2,106,209). The prepared compounds show significant antiisoprenaline activity, comparable to the Praktolol standard. The antiarrhythmic activity is lower than the propranolol standard.
Orientačně hodnotenie akútnej toxicity s. c. aplikovaných vodných roztokov študovaných látok ukázalo, že LDso týchto látok sa pohybuje v rozmedzí 300—600 mg.kg-1, čo odpovedá toxicitě v kllnickej praxi používaných beta-adrenolytík (například Trimepranolu). Látky všeobecného vzorca I je možné podía vynálezu připravit různými spůsobmi, a to tak, že sa nechá reagovat' a) zlúčenina všeobecného vzorca IIAs an indicative evaluation of acute toxicity sc of applied aqueous solutions of the studied substances showed that the LD 50 of these substances is in the range of 300-600 mg.kg -1 , which corresponds to the toxicity in clinical practice of used beta-adrenolytics (for example Trimepranol). The compounds of the formula I can be prepared in various ways according to the invention by reacting a) a compound of the formula II
OH í OOH í O
C'CO-R“ (li) v ktoromC'CO-R '(li) in which
R2 znamená to isté ako vo vzorci I s primárným amínom všeobecného vzorca R2 is the same as in formula I with a primary amine
NH2R1 v ktoromNH 2 R 1 wherein
R1 znamená to isté, ako vo vzorci I b) zlúčenina všeobecného vzorca III .0, ^ch^o-r vR 1 is the same as in formula I b) a compound of formula III
i gi g
CO~R (Hl) v ktoromCO-R (H1) wherein
R2 znamená to isté, ako vo vzorci I s primárným amínom všeobecného vzorca R2 is the same as in formula I with a primary amine
NH2—R1 v ktoromNH 2 -R 1 wherein
Rt znamená to isté, ako vo vzorci I cj zlúčenina všeobecného vzorca IVRt is the same as in formula I cj of the compound of formula IV
R2 znamená to isté, ako vo vzorci I s 1-alkylamíno-2,3-epoxypropánom všeobecného vzorca V R2 is the same as in formula I, with 1-alkylamino-2,3-epoxypropane of the formula V
CH2—CH—CH2—NH—Ri (Vj \/CH2 - CH - CH2 - NH - R1 (Vj)
O v ktoromAbout which
R1 znamená to isté, ako vo vzorci I dj zlúčenina všeobecného vzorca IV, v ktorom R2 znamená to isté, ako vo vzorci I s l-alkylamino-3-chlór-2-propanolom všeobecného vzorca VIR 1 is the same as in formula I dj a compound of formula IV wherein R 2 is the same as in formula I with 1-alkylamino-3-chloro-2-propanol of formula VI
Cl—CHz— CH—CH2—NHR1 (VI)Cl — CH2 — CH — CH2 — NHR 1 (VI)
II
OH v ktoromOH in which
R1 znamená to isté ako vo vzorci I.R 1 is the same as in formula I.
Pri príprave podía vynálezu prebieha reakcia medzi obidvoma východiskovými zložkami v spósoboch a) a b] v prostředí alkoholu pri teplote varu reakčnej zmesi. V sposoboch cj a d) prebieha reakcia v prostředí vody za katalytického účinku hydroxidu alkalického kovu, například hydroxidu sodného pri teplote miestnosti. Po skončení reakcie sa reakčná zmes spracuje po oddestilovaní organického rozpúšťadlá vytrepaním bázy do éteru. Z tohto roztoku je možné připravit priamo sol, ktorá sa dá čistit kryštalizáciou z organického rozpúšťadlá alebo zo zmesi rozpúštadiel. Z připravených solí sa ako vhodné ukázali soli s organickými kyselinami, například fumarát, citrát, šťavelan, vínan atd. Podrobnosti přípravy sú uvedené v nasledujúcich príkladoch.In the preparation according to the invention, the reaction between the two starting materials in processes a) and b) is carried out in an alcohol medium at the boiling point of the reaction mixture. In processes cj and d), the reaction is carried out in water under the catalytic action of an alkali metal hydroxide, for example sodium hydroxide, at room temperature. After completion of the reaction, the reaction mixture is worked up by distilling off the organic solvent by shaking the base into ether. From this solution, a salt can be prepared directly, which can be purified by crystallization from an organic solvent or a mixture of solvents. Of the prepared salts, salts with organic acids such as fumarate, citrate, oxalate, tartrate, etc. have proven suitable. The preparation details are given in the following examples.
Příklad 1Example 1
4- (3-Izopropylamíno-2-hydroxypropoxy) -3- (cyklohexyloxymetyl )f enyletylketón4- (3-Isopropylamino-2-hydroxypropoxy) -3- (cyclohexyloxymethyl) phenylethylketone
K roztoku 0,04 mólu 4-(2-hydroxy-3-chlórpropoxy j-3-(cyklohexyloxymetyl jfenyletylketónu v 50 ml 2-propanolu sa přidá 0,05 mólu izopropylamínu. Reakčná zmes sa zahrieva 24 hodin pri teplote varu reakčnej zmesi. Po vychladnutí reakčnej zmesi sa rozpúšťadlo a nezreagovaný amin vákuovo oddestilujú, zvyšok sa rozpustí v zriedenej kyselině chlorovodíkovej, pretrepe trikrát éterom a z vodnej vrstvy sa alkalizáciou uvolní báza, ktorá sa vytrepe do éteru. Po vysušení bzv. síranom horečnatým sa z filtrátu přidáním éterického roztoku kyseliny fumarovej vylúči fumarát, ktorý sa prekryštalizuje z etylacetátu; t. t. 164—165 °C.To a solution of 0.04 mol of 4- (2-hydroxy-3-chloropropoxy) -3- (cyclohexyloxymethyl) phenylethyl ketone in 50 ml of 2-propanol is added 0.05 mol of isopropylamine and the reaction mixture is heated at reflux for 24 hours. After cooling the reaction mixture, the solvent and the unreacted amine are distilled off in vacuo, the residue is dissolved in dilute hydrochloric acid, shaken three times with ether and the base is alkalinized to give an alkaline solution which is shaken into ether. of fumarate, which is recrystallized from ethyl acetate, mp 164-165 ° C.
IČ vas coo~ = 1580 cm1;IR at as coo ~ = 1580 cm @ -1 ;
VArocH2 = 1256 cm-1;VArocH 2 = 1256 cm -1 ;
UV λ = 208, 222, 275 nm, (loge = 3,33; 3,32; 3,27 m2. mol1] tH-NMR δ =UV λ = 208, 222, 275 nm, (loge = 3.33; 3.32; 3.27 m 2 mol 1 ) 1 H-NMR δ =
4,00 (široký pás 3H; Ar-OCH2-CHj,4.00 (broad band 3H; Ar-OCH 2 -CH 3,
0,95 (6H; d; CHfCHsjz] ppnT Příklad 20.95 (6H; d; CH 2 CH 2 O 2) ppnT Example 2
4- (3-Izopropylamíno-2-hydroxypropoxy J -3- (alyloxymetyl j f enyletylketón4- (3-Isopropylamino-2-hydroxypropoxy) -3- (allyloxymethyl) phenylethylketone
K roztoku 0,08mólu4-(2,3-epoxyipropoxyj-3-(allyloxymetyl)fenyletylketónu v 100 ml etylalkoholu sa přidá 0,016 mólu izopropylaminu. Reakčná zmes sa zahrieva 3 hodiny pri teplote 30 °C a 4 hodiny pri teplote varu reakčnej zmesi. Po ukončení reakcie sa rozpúšťadlo a nezreagovaný amin oddesti252518 lujú, k zvyšku sa přidá 50 ml vody a báza sa trikrát vytrepe do éteru. Po vysušení bzv. síranem horečnatým sa z filtrátu přidáním éterického roztoku kyseliny fumarovej vyléčí fumarát, ktorý sa prekryštalizuje z etylacetátu, t. t. 133—135 °C.To a solution of 0.08 mol of 4- (2,3-epoxyipropoxy) -3- (allyloxymethyl) phenylethyl ketone in 100 ml of ethyl alcohol was added 0.016 mol of isopropylamine, and the reaction mixture was heated at 30 ° C for 3 hours and at reflux temperature for 4 hours. After completion of the reaction, the solvent and the unreacted amine are stripped off, 50 ml of water are added to the residue, and the base is shaken three times into ether.After drying, the so-called magnesium sulfate, —135 ° C.
ič pas coo~ = 1572 cm-1;ič p as coo ~ = 1572 cm -1 ;
i*ArocH2 = 1262 cnr1;i * ArocH 2 = 1262 cm -1 ;
UV λ = 208, 219, 273 nm, (loge = 3,66; 3,67; 3,53 m2.mól_1)UV λ = 208, 219, 273 nm (log? = 3.66, 3.67, 3.53 m 2 .mol _1)
1H-NMR δ =@ 1 H-NMR .delta
4,00 p,pm (široký pás 3H; Ar-OCHz-QH),4.00 µm (broad band 3H; Ar-OCH 2 -QH),
0,95 ppm [6H; d; CH(CHs)2]0.95 ppm [6H; d; CH (CH 2 ) 2 ]
Příklad 3Example 3
4- (3-Izopropylamíno-2-hydroxypropoxy) -3- (alyloxymetyl )f enylmetylketónu4- (3-Isopropylamino-2-hydroxypropoxy) -3- (allyloxymethyl) phenylmethylketone
Roztok 0,02 molu 3-alyloxymetyl-4-hydroxyfenylmetylketónu, 3 ml 1-izopropylamíno-2,3-epoxypropánu a 20 ml vody s 0,2 ml konc. roztoku hydroxidu sodného sa mieša 6 hodin pri teplote miestnosti. Z vytvorenej olejovitej vrstvy sa příslušná báza získá vytrepanim reakčnej zmesi éterom. Po vysušení éterického roztoku sa přidáním éterického roztoku kyseliny fumarovej vylúči fumarát, ktorý sa prekryštalizuje z etylacetátu; t. t. 131—132 °C.A solution of 0.02 mol of 3-allyloxymethyl-4-hydroxyphenylmethyl ketone, 3 ml of 1-isopropylamino-2,3-epoxypropane and 20 ml of water with 0.2 ml conc. of sodium hydroxide solution was stirred at room temperature for 6 hours. From the oily layer formed, the corresponding base is obtained by shaking the reaction mixture with ether. After drying the ethereal solution, the addition of an ethereal fumaric acid solution precipitates a fumarate which is recrystallized from ethyl acetate; t. t. 131-132 ° C.
ič »as coo~ = 1576 cm -1;ič as as coo ~ = 1576 cm - 1 ;
»ArocH2 = 1256 cm-1;»ArocH 2 = 1256 cm -1 ;
UV Λ = 206, 219, 273 nm, (loge = 3,63; 3,65; 3,52 m2.móll) iH-NMR δ =UV Λ = 206, 219, 273 nm, (loge = 3.63; 3.65; 3.52 m2.mol) 1 H-NMR δ =
4,00 ppm (široký pás 3H; Ar-OCHž-CH),4,00 ppm (broad band 3H; Ar-OCH 2 -CH),
0,95 ppm [6H; d; CH(CH3)2]0.95 ppm [6H; d; CH (CH3) 2]
Příklad 4Example 4
4- (3-terc.Butylamíno-2-hydroxypropoxy j -3 (alyloxymetyl) f enylmetylketón4- (3-tert-Butylamino-2-hydroxypropoxy) -3 (allyloxymethyl) phenylmethylketone
K 0,02 uiólu 3-allyloxymetyl-3-hydroxyfenylmetyliketonu, 0,02 molu hydrochloridu 1-chlór-3-terc.butylamíno-2-propanolu sa přidá 60 ml 4 % roztoku hydroxidu sodného. Reakčná zmes sa mieša pri teplote miestnosti 24 hodin. Po vysušení sa z filtrátu přidáním éterického roztoku kyseliny fumarovej vylúči fumarát, ktorý sa prekryštalizuje z etylacetátu; t. t. 178—180 °C.To 0.02 mol of 3-allyloxymethyl-3-hydroxyphenylmethyl ketone, 0.02 mol of 1-chloro-3-tert-butylamino-2-propanol hydrochloride was added 60 ml of 4% sodium hydroxide solution. The reaction mixture was stirred at room temperature for 24 hours. After drying, the fumarate is precipitated from the filtrate by addition of an ethereal fumaric acid solution and recrystallized from ethyl acetate; t. t. 178-180 ° C.
IČ i,as coo~ = 1579 cm-1;IR, as coo = 1579 cm- 1 ;
l*ArOCH2 = 1269 cm-1;l * ArOCH 2 = 1269 cm -1 ;
UV λ = 204, 218, 273 cm1, (loge = 3,65; 3,67; 3,52 m2.mól-1j í-H-NMR δ =UV λ = 204, 218, 273 cm 1 , (loge = 3.65; 3.67; 3.52 m 2 .mol -1 H-NMR δ =
0,07 ppm [s; 9H; C(CH3)3]0.07 ppm [s; 9H; C (CH 3) 3]
S použitím uvedených metod boli připravené tieto nové látky:The following new substances were prepared using these methods:
1.First
4- (3-izopropylamíno-2-hydroxypropoxy )-3- (cyklohexyloxymetyl j f enylmetylketón fumarát,4- (3-isopropylamino-2-hydroxypropoxy) -3- (cyclohexyloxymethyl) phenylmethylketone fumarate,
1.1. 164—165 °C (etylacetát)1.1. 164-165 ° C (ethyl acetate)
2.Second
4- (3-terc.butylamíno-2-hydroxypropoxy) -3- (cyklohexyloxymetyl) f enylmetylketón fumarát,4- (3-tert-butylamino-2-hydroxypropoxy) -3- (cyclohexyloxymethyl) phenylmethylketone fumarate,
t. t. 209—210 °C (etylacetát]t. t. 209-210 ° C (ethyl acetate)
3.Third
4- (3-izopropylamíno-2-hydroxypropoxy) -3- (cyklohexyloxymetyl) fenyletylketón fumarát,4- (3-isopropylamino-2-hydroxypropoxy) -3- (cyclohexyloxymethyl) phenylethylketone fumarate,
t. t. 171—174 °C (etylacetát)t. t. 171-174 ° C (ethyl acetate)
4.4th
4-(3-terc.butylamíno-2-hydroxypropoxy )-3- (cyklohexyloxymetyl) fenyletylketón fumarát,4- (3-tert-butylamino-2-hydroxypropoxy) -3- (cyclohexyloxymethyl) phenylethylketone fumarate,
t. t. 217—220 °C (etylacetát]t. t. 217-220 ° C (ethyl acetate)
5.5th
4- (3-izopr opylamíno-2-hydr oxypropoxy) -3- (alyloxymetyl) f enylmetylketón fumarát4- (3-Isopropylamino-2-hydroxypropoxy) -3- (allyloxymethyl) phenylmethylketone fumarate
t. t. 131—132 °C (etylacetát)t. t. 131-132 ° C (ethyl acetate)
6.6th
4-(3-terc.butylamíno-2-hydroxypropoxy)-3- (alyloxymetyl) f enylmetylketón fumarát4- (3-tert-butylamino-2-hydroxypropoxy) -3- (allyloxymethyl) phenylmethylketone fumarate
t. t. 178—180 °C (etylacetát)t. t. 178-180 ° C (ethyl acetate)
7.7th
4- (3-izopr opylamíno-2-hydr oxypropoxy) -3-alyloxymetyl)fenyletylketón fumarát4- (3-Isopropylamino-2-hydroxypropoxy) -3-allyloxymethyl) phenylethylketone fumarate
t. t. 133—135 °C (etylacetát)t. t. 133-135 ° C (ethyl acetate)
8.8th
4- (3-terc.butylamíno-2-hydroxypropoxy) -3- (alyloxymetyl jfenyletylketón fumarát4- (3-tert-butylamino-2-hydroxypropoxy) -3- (allyloxymethyl) phenylethylketone fumarate
4,00 ppm. (široký pás 3H; Ar-OCHž-CH),4.00 ppm. (wide band 3H; Ar-OCH 2 -CH),
1.1. 175—177 °C (etylacetát)1.1. 175-177 ° C (ethyl acetate)
Připravené fumaráty sú v pomere báza-kyselina fumarová 2:1. Štruktúra pripravených zlúčenín bola overená elementárnou analýzou (uhlík, vodík, dusík) a vyhodnotením ultrafialových, infračervených a 1H-NMR spektier.The prepared fumarates are in a 2: 1 base-fumaric acid ratio. The structure of the prepared compounds was verified by elemental analysis (carbon, hydrogen, nitrogen) and evaluation of ultraviolet, infrared and 1H-NMR spectra.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS856717A CS252518B1 (en) | 1985-09-20 | 1985-09-20 | 4-(3-alkylamino-2-hydroxypropoxy)-3-(alkoxymethyl)phenylalkylketones and method of their preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS856717A CS252518B1 (en) | 1985-09-20 | 1985-09-20 | 4-(3-alkylamino-2-hydroxypropoxy)-3-(alkoxymethyl)phenylalkylketones and method of their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS671785A1 CS671785A1 (en) | 1987-01-15 |
| CS252518B1 true CS252518B1 (en) | 1987-09-17 |
Family
ID=5414855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS856717A CS252518B1 (en) | 1985-09-20 | 1985-09-20 | 4-(3-alkylamino-2-hydroxypropoxy)-3-(alkoxymethyl)phenylalkylketones and method of their preparation |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS252518B1 (en) |
-
1985
- 1985-09-20 CS CS856717A patent/CS252518B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS671785A1 (en) | 1987-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU638252A3 (en) | Method of obtaining aminoethanol derivatives or salts thereof | |
| US4145426A (en) | Anti-microbial piperidino butan-2-ones | |
| US5239077A (en) | Highly pure amidoximes | |
| JP2792046B2 (en) | Optically active amine-boron compound, asymmetric reducing agent containing the same as an active ingredient, and method for producing optically active compound using the same | |
| WO2004101540A2 (en) | Method for the production of phenylacetic acid derivatives | |
| FI84598B (en) | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA AMINOALKYLSUBSTITUERADE UREA-DERIVAT OCH DERAS SYRAADDITIONSSALTER. | |
| US4968808A (en) | Process for the preparation of nitroethene derivatives | |
| JPS6223742B2 (en) | ||
| US4623724A (en) | Method for the production of nuclear substituted cinnamoylanthranilic acid salts | |
| US4665197A (en) | Process for preparing azetidine derivatives and intermediates thereof | |
| JPH07116116B2 (en) | Process for producing 3-aminoacrylic acid ester | |
| US4280958A (en) | Process for producing indoline derivative | |
| JPS6026154B2 (en) | Production method of basic oxazine dye | |
| JPS5834471B2 (en) | chemical compounds | |
| CA1054597A (en) | 1,6,7,8-tetrahydro-4-oxo-4h-pyrido (1,2-a) pyrimidine-9-carboalkoxy compounds | |
| US4091095A (en) | Phosphinyl compounds | |
| JP3084871B2 (en) | N-acyl-O- (3-chloro-2-propenyl) hydroxylamine and method for producing the same | |
| US4873343A (en) | Process for the preparation of N-(2-chlorobenzyl)-2-(2-thienyl) ethylamine | |
| DE3815046A1 (en) | 3-CHLORINE-2-METHYLPHENETHYLAMINE DERIVATIVES | |
| JP2000044549A (en) | Benzotriazole derivative | |
| US4034045A (en) | 2,4-Disubstituted-4b,5,6,7,8,8a,9,10-octahydro-9-oxo-phenanthrenes | |
| DE69818653T2 (en) | METHOD FOR PRODUCING (+/-) 3- (3,4-DICHLOROPHENOL) -2-DIMETHYLAMINO-2-METHYLPROPAN-1-OL OR CERICLAMINE (INN) | |
| SK6952001A3 (en) | Processes for the preparation of (p-chlorophenyl)propanol derivatives | |
| US4188343A (en) | Process for preparing anthranylaldehyde derivatives | |
| JP3530925B2 (en) | Method for producing oxoester compound |